Knife and Sword Ban

Debate between Rushanara Ali and Alex Norris

Tuesday 6th February 2024 Commons Chamber

[Alex Norris]

I am going to set out a few of them shortly, but I would be very interested in meeting Leanne and Mandy, if my hon. Friend could help facilitate that, to hear what more they might want to see.

Our commitment is for every offender to be referred to a youth offending team and have a mandatory bespoke action plan to prevent reoffending. As part of that we need tougher new guidance so that serious penalties are always considered where appropriate, such as curfews, tagging and behavioural contracts. Too many of these are being overlooked and insufficient sanctions such as a letter of apology being used in their stead. That is wrong; we need stronger guidance from the centre on this. But speaking to the point made by the right hon. Member for Orkney and Shetland (Mr Carmichael), all of this on its own will not resolve and remove the issue of knife crime in our communities.

We must invest in young people, because prevention is better than cure. We need a total approach—not an either/or, but both. That is particularly germane to this debate, because we know that those who seek to profit from the sale of dangerous weapons shapeshift and adapt around legislation—that is one of the challenges. So we must tackle demand and tackle issues that mean that young people think they need to carry harmful weapons.

Building on the success of Sure Start—the last truly transformative prevention programme for young children—we would create the Young Futures programme to help prevent violent crime. It would be a targeted programme in every area to identify the young people most at risk of being drawn into violent crime and of buying these products that we are seeking to restrict. We would build around them a package of support that responds to the challenges they face.

[Rushanara Ali (Bethnal Green and Bow) (Lab)]

As well as providing support to young people—I welcome the £100 million of existing funding to divert and support young people through preventive work—does my hon. Friend agree that it is crucial to provide positive role models through mentoring to every young person in the country? I have worked on that with the charity UpRising, which I have chaired for many years. Does he also agree that we should look at institutions such as the Royal London Hospital and its trauma unit, which has worked on the frontline dealing with the results of knife crime, whether in hospitals or out with paramedics? We can draw on a great deal of knowledge to tackle this epidemic.

[Alex Norris]

I am grateful to my hon. Friend for that intervention, because she has done incredible work that is admired by me and the shadow Home Secretary. A lot of what I am about to talk about is based on that experience, because that work has been very good.

The Young Futures programme will bring together services locally to better co-ordinate the delivery of preventive, evidence-based interventions around a young person that help to tackle mental health issues, substance abuse issues, and issues that people might get into with their friends and family. We will then bring that together in a national network that shares evidence, delivers support for teenagers at risk of being drawn into crime across boundaries and, where appropriate, could deliver universal youth provision. Then, crucially—this speaks to the point just made by my hon. Friend the Member for Bethnal Green and Bow (Rushanara Ali)—we would build out from that, with youth workers in accident and emergency units and in custody centres, and with mentors in pupil referral units, to target young people who are starting to be drawn to violence.

Those are change moments, particularly in healthcare and custody settings. We know it might be the moment when an individual who is sliding into serious violence, whether as a perpetrator or a victim, may need that intervention. It might be the moment where we can get that change in behaviour that will in many cases save their lives. That is why it is so crucial that we have this degree of investment into young people, because otherwise such measures will not work.

Town Centre Safety

Debate between Rushanara Ali and Alex Norris

Tuesday 5th December 2023 Commons Chamber

[Alex Norris]

I am very grateful to the hon. Gentleman for seeking to explain to me my own amendment to that legislation. I promise him that I will get to that point. I will not break that promise; I will explain the difference in detail shortly.

Retailers, unions, representative bodies, staff and management are totally aligned on the need for action—action that I will set out shortly when I detail our alternative, which is expressed in the motion. But first we must address this question: how did we end up here? The blame lies squarely at the door of this Government, following 13 and a half years of making the lives of criminals easier. Take first the disastrous decision to cut 20,000 police officers—a decision so damaging that they have spent the past five years desperately seeking to plug the gap. The loss of each officer from the frontline emboldened those who seek to do down our town centres. Those who cause disruption and crime today learned their skills and gained their confidence in an environment of hollowed-out policing.

[Rushanara Ali (Bethnal Green and Bow) (Lab)]

Does my hon. Friend agree that there is a link between the 10,000 cut in the number of neighbourhood officers and police community support officers since 2015 and the increase in shoplifting? Does he also agree that it is irresponsible of the Government to call for citizen’s arrests instead of being tough on crime and the causes of crime?

Medicines and Medical Devices Bill (First sitting)

Debate between Rushanara Ali and Alex Norris

Committee stage & Committee Debate: 1st sitting: House of Commons
Monday 8th June 2020 Public Bill Committees

[Rushanara Ali (Bethnal Green and Bow) (Lab)]

It is absolutely right that there should be some way of setting out a hierarchy, with public safety at the top. Like my hon. Friend, I have a major project in my constituency to promote the life sciences, through The Royal London Hospital, Queen Mary University of London and others. It would be great for investment and we want to see that happen. However, in the light of what has recently happened and the public loss of confidence in the focus on public safety, particularly with reference to chlorinated chicken and the rest of it, the public feel great concern about safety. It is important that the Minister is able at least to provide the reassurance that public safety would be at the top of the agenda, with some sort of hierarchy.

[Alex Norris]

I completely agree. I think that if we stood in the street for a bit and just straw-polled people, everybody would say that safety is uppermost and they would see the value in its being set on a higher tier, which is what I am suggesting. We are at this possibly significant moment—I believe it is 8 July—when the noble Baroness Cumberlege will come back with her review into what has happened. Obviously, it is a sign of the times and where we are, but at Second Reading people talked about it coming out in March. The world has passed us by, but I understand that publication of the review is imminent and I am keen for that date of 8 July to be confirmed.

If the review says that there are issues around patient safety, we would expect there to be recommendations and changes, which I think is reasonable. I will return to this theme later in the day. What might this say about the MHRA? Is it possible that the regime that we seek to put in place through the Bill might be overrun by events? If recommendations come out of that, is there a possibility of revisiting that in future stages to be clear about it? That is an argument against the sort of piecemeal regime that the Bill proposes, instead of coming back in, if not two years, then three or four, to set a full codified bringing together of the different Acts into one Bill.

I will finish on amendment 23 by referring to one of my favourite contributions from Second Reading:

“Patient safety is not a partisan issue; it is paramount.”—[Official Report, 2 March 2020; Vol. 672, c.689.]

The Minister may recognise her words. I completely agree with her.

Amendments 24 to 27 essentially make the same provisions across veterinary medicines and medical devices, and I do not intend to rehearse the arguments. On medical devices, surgical matters was a good example. There is the potential for life-changing and wonderful things, but also the real potential to do harm. We want to know that with every hip, breast, knee—whatever it is that is done—safety is paramount. Amendments 22 and 23 seek to create a special place for patient safety. I hope that the Minister will accept them.

[Jo Churchill]

First, patient safety is paramount. That is where I began my journey into Parliament. In my case, it was access to cancer drugs—something close to my heart. With regard to Orkambi, I understand and share the frustration felt by everyone. My heart goes out to those affected, who are very often parents. The cystic fibrosis campaign has, I think, a 98% sign up of all parents who have had children with cystic fibrosis. On their fight for Orkambi, I am sure everybody feels sympathy for them, because it took so long to provide access.

Drug companies have a responsibility here. This refers slightly to the comments the hon. Member for Nottingham North made about life science sectors or pharmaceutical companies all being large. The drug companies have a responsibility to price their drugs responsibly in a way that reflects the benefits that they bring to patients. I feel that the arrangements that we have in place in the National Institute for Health and Care Excellence and the cancer drugs fund have helped people to get access to medicines rapidly. There is still work to do, but they need to be marketised at a fair price. We made a commitment in our manifesto to establish an innovative medicines fund to address slightly some of the points that he made.

Amendments 22 to 27 relate to the three considerations the appropriate authority must have regard to when making regulations in relation to medicines for human and veterinary use and medical devices. The effect of the amendment would be to remove the requirement to have due regard to the attractiveness of the UK as a place to market and develop these products, and to assert the primacy of patient safety above all other considerations.

The safety of patients and the environment, people and animals—when moving into the area of veterinary medicine—absolutely underpins the regulatory decisions that are made. It is absolutely the case that we would never seek to make a regulatory change that puts somebody’s health at risk; that would be counter-intuitive. However, I do not think that patient safety or safety in general is in conflict with the other considerations that these amendments are intended to affect.

The purpose of the regulation is to ensure that we do what is in the best interests of UK patients, or the veterinary sector when it comes to animals, so that they receive the best possible treatment without undue impact on the environment. It is likely that having a dynamic and innovative market, where treatments or technologies are developed in the UK, contributes to the overall benefit of the patient, as those treatments will become available to them. These are not binary principles where regulation works only in the interests of one or the other.

The hon. Member for Nottingham North mentioned Nottingham—I also shout out to Cambridge, which is just down the road, and London, which the hon. Member for Bethnal Green and Bow mentioned. This country’s life sciences sector is envied. The Government have committed to supporting it through the life science industrial strategy, in which we have sought to address the challenges faced by the industry and provide an environment that encourages companies to start and grow. All large companies start somewhere, and the hon. Member for Nottingham North knows that in the incubators around Nottingham, Cambridge and even my constituency of Bury St Edmunds, lots of small firms are working on the most incredible things to help patients.